Table 2.

Phenotypic characterization of the lymphocyte compartment and somatic hypermutations in ICOS deficiency




Age at testing, y

Lymphocyte count, × 109/L

CD3, %Ly

CD4, %Ly

CD8, %Ly

CD19, %Ly

CD19/μL

CD27-IgD+, %Bc

CD27+IgD+, %Bc

CD27+IgD-, %Bc

SHM, %bp
Family A            
    Patient 1   41   1.266   95.6*  59.2*  31.9   0.6*  7*  89.6*  5.9*  0.8*  ND  
    Patient 2   32   1.047   88.5*  39.9   47.2*  0.6*  9*  88.5*  7.8*  1.6*  3.8  
Family B            
    Patient 3   35   1.171   77.6   50.5   22.8   2.8*  34*  94.9*  4.1*  0.2*  
    Patient 4   25   0.353*  91.9*  44.8   33.6   3.2*  5*  92.9*  5.1*  0.3*  ND  
Family C            
    Patient 5   46   0.871*  72.2   55.1   16.6   14.6   127   90.4*  9   0.2*  2.2* 
    Patient 6   42   1.722   91.9*  23.1   64.0*  2.01*  33*  90.2*  11.3   1.3*  ND  
Family D            
    Patient 7   18   3.031   88.5*  40.8   47.5*  6.1   184   96.8*  2.7*  0*  
    Patient 8   5   3.584   76.1   39.0   34.5   19.1   686   95.2*  3.2*  1.3*  2.3* 
    Patient 9   5   4.153   70.4   32.8   34.8   21.2   882   97.7*  2*  0*  
Mean ± SD   —   1.910 ± 1.262   83.6 ± 9.0   42.8 ± 10.5   37.0 ± 13.4   7.8 ± 7.7   219 ± 311   92.9 ± 3.2   5.7 ± 3.0   0.6 ± 0.6   2.8 ± 0.7  
Normal range
 

 
1.0-2.8
 
55-83
 
28-57
 
10-39
 
6-19
 
100-500
 
38-80
 
7.9-36
 
6.5-33
 
2.5-6.3
 



Age at testing, y

Lymphocyte count, × 109/L

CD3, %Ly

CD4, %Ly

CD8, %Ly

CD19, %Ly

CD19/μL

CD27-IgD+, %Bc

CD27+IgD+, %Bc

CD27+IgD-, %Bc

SHM, %bp
Family A            
    Patient 1   41   1.266   95.6*  59.2*  31.9   0.6*  7*  89.6*  5.9*  0.8*  ND  
    Patient 2   32   1.047   88.5*  39.9   47.2*  0.6*  9*  88.5*  7.8*  1.6*  3.8  
Family B            
    Patient 3   35   1.171   77.6   50.5   22.8   2.8*  34*  94.9*  4.1*  0.2*  
    Patient 4   25   0.353*  91.9*  44.8   33.6   3.2*  5*  92.9*  5.1*  0.3*  ND  
Family C            
    Patient 5   46   0.871*  72.2   55.1   16.6   14.6   127   90.4*  9   0.2*  2.2* 
    Patient 6   42   1.722   91.9*  23.1   64.0*  2.01*  33*  90.2*  11.3   1.3*  ND  
Family D            
    Patient 7   18   3.031   88.5*  40.8   47.5*  6.1   184   96.8*  2.7*  0*  
    Patient 8   5   3.584   76.1   39.0   34.5   19.1   686   95.2*  3.2*  1.3*  2.3* 
    Patient 9   5   4.153   70.4   32.8   34.8   21.2   882   97.7*  2*  0*  
Mean ± SD   —   1.910 ± 1.262   83.6 ± 9.0   42.8 ± 10.5   37.0 ± 13.4   7.8 ± 7.7   219 ± 311   92.9 ± 3.2   5.7 ± 3.0   0.6 ± 0.6   2.8 ± 0.7  
Normal range
 

 
1.0-2.8
 
55-83
 
28-57
 
10-39
 
6-19
 
100-500
 
38-80
 
7.9-36
 
6.5-33
 
2.5-6.3
 

Lymphocyte subpopulations were analyzed by flow cytometry with the following markers: CD3 for total T cells and CD4 and CD8 for the respective subpopulations, CD19 for B cells with naive (CD27-IgD+), IgM memory (CD27+IgD+), and switched memory (CD27+IgD-) subpopulations. Normal ranges are determined for adult population.

%Ly indicates percentage of lymphocytes; %Bc, percentage of B cells; SHM, somatic hypermutation; %bp, percentage of mutated base pairs; ND, not determined; —, not applicable.

*

Pathologic values.

The percentage of CD19+CD27+ cells was too low for analysis.

or Create an Account

Close Modal
Close Modal